Characteristics of type 2 diabetic patients and healthy control subjects
| . | Type 2 diabetic patients . | Control subjects . | P . |
|---|---|---|---|
| n | 114 | 112 | — |
| Sex (%) | |||
| Male | 57.9 | 58.9 | NS |
| Female | 42.1 | 41.1 | NS |
| Age (years) | 63.9 ± 9.3 | 51.1 ± 7.5 | <0.001 |
| BMI (kg/m2) | 28.6 ± 5.0 | 27.9 ± 3.6 | NS |
| Diabetes duration (years) | 10.4 ± 7.8 | — | — |
| Fasting plasma glucose (mmol/l) | 9.2 ± 2.7 | 5.3 ± 0.5 | <0.001 |
| HbA1c (%) | 8.4 ± 1.5 | 5.4 ± 0.5 | <0.001 |
| Fasting plasma C-peptide (ng/ml) | 1.70 ± 1.08 | — | — |
| Fasting plasma insulin (μU/ml) | 12.59 ± 15.59 | — | — |
| Therapy (%) | |||
| Diet alone | 11.4 | — | — |
| Oral hypoglycemic agents | 64.9 | — | — |
| Insulin (alone or in combination with oral hypoglycemic agents) | 23.7 | — | — |
| . | Type 2 diabetic patients . | Control subjects . | P . |
|---|---|---|---|
| n | 114 | 112 | — |
| Sex (%) | |||
| Male | 57.9 | 58.9 | NS |
| Female | 42.1 | 41.1 | NS |
| Age (years) | 63.9 ± 9.3 | 51.1 ± 7.5 | <0.001 |
| BMI (kg/m2) | 28.6 ± 5.0 | 27.9 ± 3.6 | NS |
| Diabetes duration (years) | 10.4 ± 7.8 | — | — |
| Fasting plasma glucose (mmol/l) | 9.2 ± 2.7 | 5.3 ± 0.5 | <0.001 |
| HbA1c (%) | 8.4 ± 1.5 | 5.4 ± 0.5 | <0.001 |
| Fasting plasma C-peptide (ng/ml) | 1.70 ± 1.08 | — | — |
| Fasting plasma insulin (μU/ml) | 12.59 ± 15.59 | — | — |
| Therapy (%) | |||
| Diet alone | 11.4 | — | — |
| Oral hypoglycemic agents | 64.9 | — | — |
| Insulin (alone or in combination with oral hypoglycemic agents) | 23.7 | — | — |
Data are means ± SD unless otherwise indicated.